Found: 4
ОБЗОР2024 · pp. 14–23
Venediktov A.A., Kuzmin E.A., Pokidova K.S., Oganesyan D.M., Stepanian A.T., Boronikhina T.V., Piavchenko G.A., Kuznetsov S.L
Introduction. Many chemical compounds affect brain neurons differently than other cell populations. This is provided by the protective potential of the blood-brain barrier (BBB). One of the compounds capable of passing through the BBB is bacterial lipopolysacc…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 43–51
Leontieva D.O., Zubareva A.S., Korovin A.E., Grishin A.P., Tovpeko D.V., Fedotkina T.V., Churilov L.P.
Introduction. Mitochondrial dysfunction is an important pathogenic mechanism of neurodegeneration, characterized by a progressive structural and functional loss of neurons, leading to heterogeneous clinical and pathological manifestations with subsequent impai…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Pleshakova I.M., Sufieva D.A., Korzhevskii D.E.
Introduction. Changes in the structural organization of the cell nucleus often precede the degeneration of the nerve cell. Histone H4 trimethylated on lysine 20 (H4K20me3) may act as one of the markers of neurodegenerative processes. The aim of this paper was …
ОБЗОР2018
Sapronova M.R., Shnayder N.A.
Modern methods of treatment of Parkinson's disease (PD) remain to be unsuccessful in cessation of the progression of neurodegenerative processes in the brain. The role of certain genes is proven by the etiology of PD, 10–15% of cases represent a monogenic dise…